Registered Owners
- View profile →
PT DANKOS FARMA
Jl. Rawagatel Blok III S Kav. 35-40, Kawasan Industri Pulogadung, DKI Jakarta, Indonesia
NPWP: 021893219007000
owner
Traditional MedicineValid
VENOSMIL GEL
- BPOM Number
- QI054701151
- Approved
- 15 April 2021
- Expiry
- 19 March 2025
- Form
- Gel
Registration Details
- Application
- e-Registration Obat Tradisional & Suplemen Makanan (ASROT)
- Packaging
- Dus, tube @ 60 g
- Department
- Traditional Medicine, Health Supplements & Cosmetics Directorate
Retail Audit Service
Get detailed market intelligence for this product across Indonesian retail channels
Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?
Stock availability and positioning verification
Price checking and competitor analysis
Display quality and promotional material assessment
Store condition and customer experience evaluation
Custom questions tailored to your research needs
Professional photographs and detailed reports
Manufacturing Sites
- View profile →
PT DANKOS FARMA
Jl. Rawagatel Blok III S Kav. 35-40, Kawasan Industri Pulogadung, DKI Jakarta, Indonesia
primary
Importer Declarations
PT DANKOS FARMA
Jl. Rawagatel Blok III S Kav. 35-40, Kawasan Industri Pulogadung, DKI Jakarta
importerView profile →
Ingredients (11)
AQUA DESTILATA<BR>CARBOMER 940<BR>HIDROSMIN<BR>NIPAGIN<BR>NIPASOL<BR>TRIETANOLAMIN
Market Intelligence
- Category Size
- One of 1,001 products in the Traditional Medicine category
- Owner Portfolio
- PT DANKOS FARMA holds 20 BPOM registrations
- Manufacturer Scale
- PT DANKOS FARMA produces 20 registered products
- Registration Age
- Registered for 6 years, 3 months
- Expiry Status
- Expired 466 days ago
Is this your product?
Claim it to manage registration, track renewals, and get expiry alerts.
More products from PT DANKOS FARMA
BRAINACT 1000
Brainact 1000SD051424561
Approved: May 25, 2026Serbuk Oral
BRAINACT 1000
Brainact 1000SD051522651
Approved: May 7, 2025Kaplet
LIKURMIN
LikurminSD041616021
Approved: Jan 3, 2024Cairan Oral